Visual summary
Diuretic choice follows BP versus congestion needs; thiazide safety depends on sodium, potassium, kidney function, and the response after withdrawal.
Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.
Diagram description
Drug site predicts salt and water effects. Glomerulus — Drug delivery and filtration; Proximal tubule — Bulk sodium reclamation; Loop of Henle — Loop-diuretic target; Distal tubule — Thiazide target; impaired dilution can lower sodium. Monitor sodium and symptoms in vulnerable patients; thiazides and loops are not equivalent. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.
Text version
Match nephron site to the goal
Loops inhibit the thick ascending limb and are central for congestion; thiazide-type drugs act distally and are effective BP agents. Potassium-sparing agents have distinct aldosterone/ENaC indications. Combining sites can improve natriuresis but magnifies electrolyte loss and volume risk.
Low eGFR does not settle every choice
Loop therapy often becomes important for volume control in advanced CKD. Chlorthalidone lowered BP in the stage 4 CKD CLICK trial, so “thiazides never work below eGFR 30” is too absolute. Monitor potassium, creatinine, sodium, and orthostatic symptoms closely.
Identify the vulnerable thiazide patient
Older age, low body mass/intake, prior thiazide hyponatremia, excess water, intercurrent illness, and interacting medicines raise concern. Obtain baseline sodium, potassium, creatinine, BP, and volume assessment; plan an early chemistry check after starting or increasing therapy.
New confusion or falls: check sodium
Fatigue, gait change, nausea, headache, confusion, or seizures after thiazide exposure requires evaluation. Stop/review the thiazide and assess tonicity, symptoms, and volume. Severe symptomatic hypotonic hyponatremia uses an emergency hypertonic-saline pathway, not a routine clinic dose adjustment.
Anticipate correction after withdrawal
When the drug effect resolves, water excretion can increase rapidly, especially after restoring volume or solute. Follow sodium and urine output during active correction; potassium replacement also raises sodium. Do not combine multiple correction measures without tracking the total trajectory.
Explain fluid and follow-up advice
Avoid telling every patient to “drink plenty” or restricting all fluid automatically. Give the plan appropriate to congestion or depletion, review symptoms after illness, and document the next laboratory check. Prior severe thiazide hyponatremia should strongly influence future drug selection.
